COVID-19 patients can soon be treated at home with new treatment options!
This was after the European Union’s drug regulator recommended EU member states to use Pfizer’s Paxlovid and Merck’s molnupiravir as antiviral pills. Their approval means that COVID-19 can now be treated with pills from the comfort of people’s homes.
Governments are expected to introduce these new pills as soon as they become available to control the spike in cases numbers around the world. The Paxlovid and molnupiravir pills are able to reduce hospitalization cases and death from the virus when taken as soon as the symptoms start to appear.
These pills should be taken by people with mildly or moderately affected by the virus at risk of becoming more ill. This includes people considered vulnerable including older people and others with health conditions. However, the pills are not meant to be taken by children as they may interfere with bone growth. Pregnant women are also advised not to take the pills as they can risk birth defects in babies.
When noticing common symptoms of the virus such as coughing, headaches, fever, loss of taste or smell and muscle and body aches, the pills should be taken immediately. In fact, infectious disease specialist Dr. Cameron Wolfe said, “If you wait until you have started to get breathless, you have already to a large extent missed the window where these drugs will be helpful.”
The treatment pills should also be effective against the Omicron variant as they are meant to work in different ways to prevent the reproduction of the virus, therefore controlling the spread.